HB 4734 expands who can legally consent to medical treatment for patients unable to make decisions themselves. It adds "designated surrogates" (people formally appointed under Michigan's Estates Code) to the list of authorized decision-makers, alongside relatives, patient advocates, and guardians. This directly affects patients without decision-making capacity, healthcare providers needing consent, and the individuals authorized to act for them. The bill clarifies that emergency care can still be provided without consent during urgent situations requiring immediate action.
HB 4418 updates Michigan's probate law to clarify how patients can designate a healthcare surrogate when they cannot make decisions themselves. It adds a new process for formally naming a surrogate (replacing the previous method) and removes an outdated section from older law. This directly affects patients without existing advance directives and their families by providing a clearer, more modern way to appoint someone to make medical decisions for them.
HB 4419 adds legal protections to Michigan's health care decision-making framework. It shields health care providers and facilities from liability when following decisions made by a legally designated patient surrogate or advocate, as long as they act in good faith. The bill also protects surrogates and advocates from liability for good-faith health care decisions they make. Providers who intentionally violate these rules face minimum damages of $1,000, while those who falsify or tamper with a patient's health care directive designation face minimum damages of $2,500. This directly affects patients with advance directives, their designated surrogates, and medical providers.
HB 4277 amends Michigan's health licensing law to remove all questions about applicants' mental health from license applications, except for two specific questions already required: whether an applicant poses a risk to patient safety and whether they can perform essential job functions. This change affects health professionals seeking initial licensure or renewal, including doctors, dentists, and nurses. The bill prohibits the department from including any additional mental health inquiries on application forms. It directly simplifies the licensing process by limiting mental health disclosures to the two existing questions.
HB 5051 amends Michigan's law to allow trained law enforcement officers and firefighters to administer epinephrine auto-injectors to individuals experiencing severe allergic reactions (anaphylaxis), even without a prescription or prior allergy diagnosis. It requires responders to complete training on proper administration and permits eligible entities (like police departments or fire stations) to purchase and distribute epinephrine devices to their staff. The bill provides legal immunity from civil liability for entities and responders acting in good faith, unless their conduct involves gross negligence or willful misconduct. This directly affects first responders who may use the devices during emergencies and individuals suffering acute allergic reactions.
HB 5053 requires medical control authorities to ensure all emergency medical services (EMS) agencies and personnel provide epinephrine or auto-injectors and are trained to recognize anaphylaxis, administer epinephrine, and properly dispose of devices. This directly affects EMS providers who deliver prehospital care across Michigan, mandating specific equipment availability and training protocols. The bill amends existing public health code requirements to strengthen emergency response capabilities for severe allergic reactions, with no changes to opioid antagonist or defibrillator requirements.
HB 5049 requires Michigan public schools to ensure trained staff can administer epinephrine auto-injectors during allergic emergencies. Schools with 10+ staff must have at least two trained employees (or one for smaller schools), and all schools must maintain at least two epinephrine auto-injectors. The bill mandates school policies for safe administration (by nurses or trained staff), reporting of all epinephrine uses to the state, and allows school districts to seek state reimbursement for unfunded costs. It directly affects all public K-12 schools in Michigan and students with severe allergies. The bill is tied to five companion bills (HB 5050-5054) that must also pass.
HB 5054 modifies Michigan's school code to clarify protections for school staff administering epinephrine auto-injectors during emergencies and to streamline student access to necessary medical devices. It ensures school employees (including non-nurses) aren’t liable for civil damages or criminal charges when administering epinephrine in good faith during life-threatening situations, except for gross negligence. The bill also allows students with asthma or severe allergies to possess and use prescribed inhalers or epinephrine devices at school, on transportation, or at school events, provided they have written medical approval and an emergency care plan on file. These changes directly affect school staff, students with medical conditions requiring epinephrine or inhalers, and school administrators managing health protocols.
HB 5050 allows schools, camps, sports leagues, and similar organizations to stock and administer EpiPen-like epinephrine auto-injectors for severe allergic reactions. It permits trained staff (not just nurses) to use these devices in emergencies without needing a specific prescription for the individual, provided they believe someone is experiencing anaphylaxis. The bill requires staff to complete initial and biennial training on recognizing allergic reactions, storing, and using epinephrine devices. It also provides legal protection for organizations and trained individuals who follow these guidelines in good faith.
HB 5052 allows children with severe allergies to carry and use epinephrine auto-injectors (like EpiPens) at children's camps under specific conditions. It directly affects minors with anaphylaxis, their parents/guardians, and camp staff. The bill requires written approval from a child's physician and parent/guardian, a camp director's verification of these approvals, and a written emergency care plan developed by a physician. It also provides legal immunity for camps that follow these protocols when allowing or denying use of the medication.
